Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q969G6
UPID:
RIFK_HUMAN
Alternative names:
ATP:riboflavin 5'-phosphotransferase; Flavokinase
Alternative UPACC:
Q969G6; Q5JSG9; Q9NUT7
Background:
Riboflavin kinase, also known as ATP:riboflavin 5'-phosphotransferase or Flavokinase, plays a pivotal role in cellular metabolism by catalyzing the phosphorylation of riboflavin (vitamin B2) to form flavin-mononucleotide (FMN). This enzyme is the rate-limiting step in the synthesis of FAD, a coenzyme essential for various biochemical reactions. Riboflavin kinase is crucial for TNF-induced reactive oxygen species (ROS) production, linking TNFRSF1A and CYBA to NADPH oxidase activation.
Therapeutic significance:
Understanding the role of Riboflavin kinase could open doors to potential therapeutic strategies. Its essential function in ROS production and the synthesis of FAD highlights its potential as a target for modulating oxidative stress-related conditions and metabolic disorders.